A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation

October 18, 2023 updated by: Xuanwu Hospital, Beijing
Systematic and professional rehabilitation training is generally effective for patients with lower limb dyskinesia, but most of them lose the chance of recovery due to failure to receive systematic rehabilitation treatment. Our team has developed an intelligent power armor for patients with lower limb motor dysfunction, which can assist patients to complete high-quality rehabilitation training. In order to evaluate the safety and efficacy of the Smart Power Armor for post-surgical spine patients, and to provide data support for a confirmatory clinical study, we designed a single-center, prospective, randomized controlled study to compare the level of recovery of lower limb motor function in patients with different rehabilitation strategies.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18-70 years old;
  • Spinal surgery within 1 year due to degeneration, tumor, trauma or other reasons, postoperative motor disorders of both lower limbs, such as muscle weakness (3-5 level reduction), increased muscle tone, gait incoordination caused by deep sensory loss, etc.;
  • The patient does not have a plan to rehabilitate in a specialized rehabilitation hospital, and plans to rehabilitate at home;

Exclusion Criteria:

  • Short expected survival from malignant diseases;
  • Muscle strength is less than grade 3, and the muscles of both lower limbs are severely atrophied;
  • Suffering from other neurological diseases;
  • Planned to undergo other surgeries within 3 months;
  • Unable to cooperate with the transmission power external armor or cooperate with the rehabilitation training due to the physical condition;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Powered Exoskeleton Group
Rehabilitation exercises with powered exoskeletons
Whether to use powered exoskeletons for exercise rehabilitation
No Intervention: Traditional Group
Rehabilitation exercises without the use of powered exoskeletons

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-minute walk test
Time Frame: 3 months
meter; distance participants walked as fast as possible in a flat corridor in six minutes
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average rate of change in muscle strength
Time Frame: 3 months
(change in muscle strength level* number of persons)/total number of persons enrolled in the group
3 months
10 meter autonomous walking test
Time Frame: 3 months
meter; participants walk ten meters at a self-selected speed
3 months
10 meter fast walking test
Time Frame: 3 months
meter; participants walk ten meters at fastest speed
3 months
rate of change in hip joint mobility
Time Frame: 3 months
(hip joint mobility with assistance - hip joint mobility without assistance)/hip joint mobility without assistance; use joint mobility scales to measure hip joint mobility
3 months
stride length
Time Frame: 3 months
centimeter; left and right legs are measured separately
3 months
rate of change in heart rate
Time Frame: 3 months
(post-training heart rate - resting heart rate)/resting heart rate
3 months
rate of change in arterial partial pressure of oxygen
Time Frame: 3 months
(post-training arterial partial pressure of oxygen - arterial partial pressure of oxygen at rest)/arterial partial pressure of oxygen at rest
3 months
adverse event incidence rate
Time Frame: 12 months
Number of cases of adverse events/number of enrollees
12 months
serious adverse event incidence rate
Time Frame: 12 months
Number of cases of serious adverse events/number of enrollees
12 months
Thigh Swing Speed
Time Frame: 3 months
degrees/second; left and right legs are measured separately
3 months
Thigh Lifting Moment
Time Frame: 3 months
Newton*Meter; left and right legs are measured separately
3 months
Thigh Swing Angle
Time Frame: 3 months
degree; left and right legs are measured separately
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 20, 2023

Primary Completion (Estimated)

September 20, 2024

Study Completion (Estimated)

November 20, 2025

Study Registration Dates

First Submitted

September 27, 2023

First Submitted That Met QC Criteria

October 18, 2023

First Posted (Actual)

October 24, 2023

Study Record Updates

Last Update Posted (Actual)

October 24, 2023

Last Update Submitted That Met QC Criteria

October 18, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • XW-NS-IPEPSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exoskeleton Device

Clinical Trials on powered exoskeletons

3
Subscribe